NARI Inari Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NARI

Price (delayed)

$58.97

Market cap

$3.37B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.52

Enterprise value

$3.35B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The revenue rose by 35% year-on-year and by 8% since the previous quarter
NARI's gross profit is up by 32% YoY and by 8% QoQ
The quick ratio has contracted by 26% YoY but it has grown by 16% from the previous quarter
Inari Medical's debt has increased by 14% YoY and by 2.2% from the previous quarter
The gross margin has contracted by 2.1% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://inarimedical.com
Peers: NVRO OFIX NUVA

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
57.17M
Market cap
$3.37B
Enterprise value
$3.35B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.51
Price to sales (P/S)
7.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.11
Earnings
Revenue
$412.89M
EBIT
-$23.99M
EBITDA
-$15.56M
Free cash flow
-$15.06M
Per share
EPS
-$0.52
Free cash flow per share
-$0.27
Book value per share
$7.86
Revenue per share
$7.54
TBVPS
$9.25
Balance sheet
Total assets
$506.53M
Total liabilities
$79.8M
Debt
$32.99M
Equity
$426.74M
Working capital
$377.27M
Liquidity
Debt to equity
0.08
Current ratio
8.8
Quick ratio
7.95
Net debt/EBITDA
1.51
Margins
EBITDA margin
-3.8%
Gross margin
88.3%
Net margin
-6.9%
Operating margin
-7.4%
Efficiency
Return on assets
-5.7%
Return on equity
-6.8%
Return on invested capital
-5.9%
Return on capital employed
-5.2%
Return on sales
-5.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
-0.81%
1 week
-5.15%
1 month
-14.08%
1 year
-7.99%
YTD
-7.22%
QTD
-4.49%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$412.89M
Gross profit
$364.61M
Operating income
-$30.36M
Net income
-$28.36M
Gross margin
88.3%
Net margin
-6.9%
The revenue rose by 35% year-on-year and by 8% since the previous quarter
NARI's gross profit is up by 32% YoY and by 8% QoQ
Inari Medical's net margin has increased by 9% from the previous quarter
The operating income has contracted by 8% from the previous quarter

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
7.51
P/S
7.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.11
The EPS has increased by 5% since the previous quarter
The price to book (P/B) is 12% lower than the last 4 quarters average of 8.5
The equity is up by 2.3% since the previous quarter
The revenue rose by 35% year-on-year and by 8% since the previous quarter
The P/S is 19% below the last 4 quarters average of 9.6

Efficiency

How efficient is Inari Medical business performance
The return on sales has increased by 15% since the previous quarter
NARI's return on invested capital is up by 14% since the previous quarter
The company's return on assets rose by 5% QoQ
The return on equity has increased by 2.9% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The quick ratio has contracted by 26% YoY but it has grown by 16% from the previous quarter
The current ratio has declined by 24% year-on-year but it is up by 17% since the previous quarter
Inari Medical's debt is 92% less than its equity
Inari Medical's debt has increased by 14% YoY and by 2.2% from the previous quarter
NARI's debt to equity is up by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.